Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Real-time Estimate Cboe BZX  -  05/23 03:09:36 pm EDT
137.91 USD   +1.22%
02:07pWhat's next for COVID-19 vaccines for youngest US children
AQ
11:48aPfizer says 3 COVID shots protect children under 5
AQ
10:26aPfizer says 3 shots of COVID-19 vaccine for children under 5 about 80% effective
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BofA Securities Upgrades Moderna to Neutral From Underperform, Adjusts Price Target to $180 From $135

01/21/2022 | 09:29am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about MODERNA, INC.
02:07pWhat's next for COVID-19 vaccines for youngest US children
AQ
11:48aPfizer says 3 COVID shots protect children under 5
AQ
10:26aPfizer says 3 shots of COVID-19 vaccine for children under 5 about 80% effective
AQ
08:39aWhat you need to know about the coronavirus right now
RE
07:19aINSIDER SELL : Moderna
MT
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/18Moderna Seeks Swissmedic Nod For COVID-19 Shot In Children Aged Six Months To Five year..
MT
05/18As COVID cases rise, U.S. health officials mull widening additional booster eligibility
RE
05/18Moderna, International AIDS Vaccine Initiative to Start Volunteer Screening for Phase 1..
MT
05/18Piper Sandler Adjusts Moderna's Price Target to $214 From $348, Reiterates Overweight R..
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 069 M - -
Net income 2022 11 501 M - -
Net cash 2022 18 081 M - -
P/E ratio 2022 5,01x
Yield 2022 -
Capitalization 54 195 M 54 195 M -
EV / Sales 2022 1,64x
EV / Sales 2023 3,33x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 136,25 $
Average target price 212,69 $
Spread / Average Target 56,1%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-46.35%54 195
LONZA GROUP AG-27.84%41 796
IQVIA HOLDINGS INC.-28.46%38 202
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567
ALNYLAM PHARMACEUTICALS, INC.-22.00%15 980